Published May 18, 2007 | Version v1
Journal article

Microarray multiplex assay for the simultaneous detection and discrimination of hepatitis B, hepatitis C, and human immunodeficiency type-1 viruses in human blood samples

  • 1. Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Review, Food and Drug Administration, Bethesda, MD 20892 (United States)
  • 2. Division of Viral Products, Center for Biologics Evaluation and Review, Food and Drug Administration, Bethesda, MD 20892 (United States)
  • 3. Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Review, Food and Drug Administration, Bethesda, MD 20892 (United States)

Description

Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus type-1 (HIV-1) are transfusion-transmitted human pathogens that have a major impact on blood safety and public health worldwide. We developed a microarray multiplex assay for the simultaneous detection and discrimination of these three viruses. The microarray consists of 16 oligonucleotide probes, immobilized on a silylated glass slide. Amplicons from multiplex PCR were labeled with Cy-5 and hybridized to the microarray. The assay detected 1 International Unit (IU), 10 IU, 20 IU of HBV, HCV, and HIV-1, respectively, in a single multiplex reaction. The assay also detected and discriminated the presence of two or three of these viruses in a single sample. Our data represent a proof-of-concept for the possible use of highly sensitive multiplex microarray assay to screen and confirm the presence of these viruses in blood donors and patients

Additional details

Identifiers

DOI
10.1016/j.bbrc.2007.03.087;
PII
S0006-291X(07)00577-3;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
356
Journal Issue
4
Journal Page Range
p. 1017-1023
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.